Favorable Response of Advanced Superior Sulcus Non-Small Cell Lung Carcinoma to Gefitinib for 11 Years Complicated by Interval Development of Small Cell Carcinoma of the Lung

Marshall Journal of Medicine
doi 10.18590/mjm.2018.vol4.iss1.8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Marshall University School of Medicine

Related search

Gefitinib-Induced Intestinal Obstruction in Advanced Non-Small Cell Lung Carcinoma: A Case Report

Oncology Letters
Cancer ResearchOncology
2015English

P3.17-05 Multimodality Treatment for Superior Sulcus Non-Small-Cell Lung Carcinomas

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Clinical Response to Chemotherapy in Non-Small Cell Lung Carcinoma Patients

International Journal of Research in Medical Sciences
2019English

P2.08: Gene Fusions Detected in Non-Small Cell Lung Carcinoma (NSCLC) and Small Cell Lung Carcinoma (SCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Gefitinib for the Treatment of Non-Small-Cell Lung Cancer

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2010English

Metachronous Lung Cancer Developing After 11 Years of Chemo-Radiotherapy in a Patient With Non-Small Cell Lung Carcinoma

Open Journal of Thoracic Surgery
2018English

Oncologic Treatment of Non-Small Cell Lung Cancer Part B: Adjuvant Chemotherapy for Resected Non-Small Cell Lung Carcinoma

2013English

Carcinoma Meningitis Secondary to Non–Small Cell Lung Cancer

Archives of Neurology
1998English

The Open Chromatin Landscape of Non-Small Cell Lung Carcinoma

Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy